Home China's National Health Commission Reports Initial Containment of Rising Cancer Incidence; Johnson & Johnson, Roche, and Merck Lead Global Pharma Revenues in 2023

China's National Health Commission Reports Initial Containment of Rising Cancer Incidence; Johnson & Johnson, Roche, and Merck Lead Global Pharma Revenues in 2023

Apr 23, 2024 21:45 CST Updated 21:45
Johnson & Johnson

Medical Device R&D and Manufacturer